RecruitingNot applicableNCT06454097

Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Tiantan Hospital
Principal Investigator
Yinyan Wang, MD and PhD
Beijing Tiantan Hospital
Intervention
Assess the response glioma to radiochemotherapy using radiogenomics-based AI model(diagnostic_test)
Enrollment
200 target
Eligibility
18 years · All sexes
Timeline
2024 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06454097 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor →

← Back to all trials